Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 May;57(1):93–102. doi: 10.1111/j.1476-5381.1976.tb07659.x

The inhibition by glucagon of the vasoconstrictor actions of noradrenaline, angiotensin and vasopressin on the hepatic arterial vascular bed of the dog.

P D Richardson, P G Withrington
PMCID: PMC1667017  PMID: 1276544

Abstract

1 The hepatic artery of the anaesthetized dog was cannulated and perfused from a femoral artery, the blood flow and perfusion pressure being monitored continuously. The sympathetic periarterial nerves were divided. 2 Dose-dependent increases in hepatic arterial vascular resistance (HAVR) resulted from intra-arterial injections of noradrenaline, angiotensin and vasopressin. 3 Single injections of glucagon (100 mug, i.a.) caused a transient significant fall in HAVR of 19.9 +/- 3.2%, and infusions of 25 mug/min of glucagon intra-arterially caused maintained reductions in HAVR of 16.9 +/- 4.2%. 4 After single injections of 100 mug glucagon intra-arterially the vasoconstrictor responses to noradrenaline, angiotensin, and vasopressin were reduced by about 85-95%. Recovery occurred in 8-10 minutes. 5 Intra-arterial infusions of glucagon, 2.5-50.0 mug/min, reduced the effects of test doses of noradrenaline, angiotensin and vasopressin throughout the period of the infusions. 6 Dose-response curves to the constrictor agents were constructed before, during and after intra-arterial infusions of 25 mug/min of glucagon. Glucagon caused a parallel shift of the curves for noradrenaline and angiotensin to the right, with no suppression of the maximum response. 7 Infusions of glucagon shifted the dose-response curve for vasopressin to the right, but, in contrast to noradrenaline and angiotensin, the shift was nonparallel and there was a suppression of the maximum response by about one-half. 8 A large dose of insulin, 10 iu, transiently reduced HAVR and caused a weak and very transient inhibition of the effect of test doses of noradrenaline. The characteristics of these effects were quite different from those of glucagon. 9 It is possible that the antagonism by glucagon of the vasoconstrictor responses of the hepatic arterial vasculature may be important in protecting this vascular bed from the effects of concomitantly released vasoconstrictor agents.

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDREWS W. H. H., HECKER R., MAEGRAITH B. G., RITCHIE H. D. The action of adrenaline, L-noradrenaline, acetylcholine and other substances on the blood vessels of the perfused canine liver. J Physiol. 1955 Jun 28;128(3):413–434. doi: 10.1113/jphysiol.1955.sp005316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bashour F. A., Geumei A., Nafrawi A. G., Downey H. F. Glucagon: its effects on the hepatic arterial and portal venous bed in dogs. Pflugers Arch. 1973 Nov 15;344(1):83–92. doi: 10.1007/BF00587444. [DOI] [PubMed] [Google Scholar]
  4. Bayliss W. M. On the local reactions of the arterial wall to changes of internal pressure. J Physiol. 1902 May 28;28(3):220–231. doi: 10.1113/jphysiol.1902.sp000911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Distler A., Liebau H., Wolff H. P. Action of angiotensin on sympathetic nerve endings in isolated blood vessels. Nature. 1965 Aug 14;207(998):764–765. doi: 10.1038/207764a0. [DOI] [PubMed] [Google Scholar]
  6. GRAYSON J., JOHNSON D. H. The effect of adrenaline and noradrenaline on the liver blood flow. J Physiol. 1953 Apr 28;120(1-2):73–94. doi: 10.1113/jphysiol.1953.sp004874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GREEN H. D., HALL L. S., SEXTON J., DEAL C. P. Autonomic vasomotor responses in the canine hepatic arterial and venous beds. Am J Physiol. 1959 Jan;196(1):196–202. doi: 10.1152/ajplegacy.1958.196.1.196. [DOI] [PubMed] [Google Scholar]
  8. Greenway C. V., Stark R. D. Hepatic vascular bed. Physiol Rev. 1971 Jan;51(1):23–65. doi: 10.1152/physrev.1971.51.1.23. [DOI] [PubMed] [Google Scholar]
  9. HEIMBURGER I., TERAMOTO S., SHUMACKER H. B., Jr Effect of surgical pituitrin upon portal and hepatic circulation. Surgery. 1960 Oct;48:706–715. [PubMed] [Google Scholar]
  10. Jonsson O., Svanvik J., Vikgren P. Regional differences in vascular tachyphylaxis to angiotensin in the cat. Angiologica. 1967;4(6):299–309. doi: 10.1159/000157714. [DOI] [PubMed] [Google Scholar]
  11. KEATINGE W. R. MECHANISM OF ADRENERGIC STIMULATION OF MAMMALIAN ARTERIES AND ITS FAILURE AT LOW TEMPERATURES. J Physiol. 1964 Nov;174:184–205. doi: 10.1113/jphysiol.1964.sp007481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Keatinge W. R. Electrical and mechanical responses of vascular smooth muscle to vasodilator agents and vasoactive polypeptides. Circ Res. 1966 Jun;18(6):641–649. doi: 10.1161/01.res.18.6.641. [DOI] [PubMed] [Google Scholar]
  13. Kelly K. A., Nyhus L. M. Angiotensin and the liver. Am J Physiol. 1966 Feb;210(2):305–311. doi: 10.1152/ajplegacy.1966.210.2.305. [DOI] [PubMed] [Google Scholar]
  14. Khairallah P. A., Page I. H., Bumpus F. M., Türker R. K. Angiotensin tachyphylaxis and its reversal. Circ Res. 1966 Aug;19(2):247–254. doi: 10.1161/01.res.19.2.247. [DOI] [PubMed] [Google Scholar]
  15. Kock N. G., Roding B., Hahnloser P., Tibblin S., Schenk W. G., Jr The effect of glucagon on hepatic blood flow. An experimental study in the dog. Arch Surg. 1970 Feb;100(2):147–149. doi: 10.1001/archsurg.1970.01340200035008. [DOI] [PubMed] [Google Scholar]
  16. Kock N. G., Tibblin S., Schenk W. G., Jr Hemodynamic responses to glucagon: an experimental study of central, visceral and peripheral effects. Ann Surg. 1970 Mar;171(3):373–379. doi: 10.1097/00000658-197003000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kock N. G., Tibblin S., Schenk W. G., Jr Modification by glucagon of the splanchnic vascular responses to activation of the sympathicoadrenal system. J Surg Res. 1971 Jan;11(1):12–17. doi: 10.1016/0022-4804(71)90044-8. [DOI] [PubMed] [Google Scholar]
  18. Mellander S., Johansson B. Control of resistance, exchange, and capacitance functions in the peripheral circulation. Pharmacol Rev. 1968 Sep;20(3):117–196. [PubMed] [Google Scholar]
  19. Regoli D., Park W. K., Rioux F. Pharmacology of angiotensin. Pharmacol Rev. 1974 Jun;26(2):69–123. [PubMed] [Google Scholar]
  20. Richardson P. D., Withrington P. G. Proceedings: The effects of glucagon on the hepatic arterial vasculature of the dog: an inhibition of the effects of vasoconstrictor agents. Br J Pharmacol. 1975 Oct;55(2):272P–273P. [PMC free article] [PubMed] [Google Scholar]
  21. Steedman W. M. Micro-electrode studies on mammalian vascular muscle. J Physiol. 1966 Oct;186(2):382–400. doi: 10.1113/jphysiol.1966.sp008041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TORRANCE H. B. The control of the hepatic arterial circulation. J Physiol. 1961 Sep;158:39–49. doi: 10.1113/jphysiol.1961.sp006752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tibblin S., Kock N. G., Schenk W. G., Jr Response of mesenteric blood flow to glucagon. Influence of pharmacological stimulation and blockade of adrenergic receptors. Arch Surg. 1971 Jan;102(1):65–70. doi: 10.1001/archsurg.1971.01350010067017. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES